National Academies Press: OpenBook
« Previous: Forum Staff
Suggested Citation:"About the Forum." National Academies of Sciences, Engineering, and Medicine. 2023. Forum on Drug Discovery, Development, and Translation: 2022 Annual Review. Washington, DC: The National Academies Press. doi: 10.17226/26954.
×
Page 19
Suggested Citation:"About the Forum." National Academies of Sciences, Engineering, and Medicine. 2023. Forum on Drug Discovery, Development, and Translation: 2022 Annual Review. Washington, DC: The National Academies Press. doi: 10.17226/26954.
×
Page 20
Suggested Citation:"About the Forum." National Academies of Sciences, Engineering, and Medicine. 2023. Forum on Drug Discovery, Development, and Translation: 2022 Annual Review. Washington, DC: The National Academies Press. doi: 10.17226/26954.
×
Page 21

Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

About the Forum The Forum on Drug Discovery, Development, and Translation of the National Academies of Sciences, Engineering, and Medicine was created in 2005 by the National Academies’ Board on Health Sciences Policy to provide a unique platform for dialogue and collaboration among thought leaders and stakeholders in government, academia, industry, foundations, and patient advocacy with an interest in improving the system of drug discovery, development, and translation. The forum brings together leaders from private-sector sponsors of biomedical and clinical research, federal agencies sponsoring and regulating biomedical and clinical research, the academic community, and patients, and in doing so serves to educate the policy community about issues where science and policy intersect. The forum convenes a few times each year to identify and discuss key problems and strategies in the discovery, development, and translation of drugs. To supplement the perspectives and expertise of its members, the forum also holds public workshops to engage a wide range of experts, members of the public, and the policy community. The forum also fosters collaborations among its members and constituencies. For more information about the Forum on Drug Discovery, Development, and Translation, please visit our website at http://www.nationalacademies.org/DrugForum. Annual Report 2022  |  19

ABOUT THE NATIONAL ACADEMIES The National Academy of Sciences, the National Academy of Engineering, and the National Academy of Medicine work together as the National Academies of Sciences, Engineering, and Medicine (the National Academies) to provide independent, objective analysis and advice to the nation and conduct other activities to solve complex problems and inform public policy decisions. The National Academies also encourage education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science, engineering, and medicine. The Health and Medicine Division (HMD), formerly known as the program unit of the Institute of Medicine, is a division of the National Academies. HMD’s aim is to help those in government and the private sector make informed health decisions by providing evidence on which they can rely. Each year, more than 3,000 individuals volunteer their time, knowledge, and expertise to advance the nation’s health through the work of HMD. Many of the studies that HMD undertakes are requested by federal agencies and independent organizations; others begin as specific mandates from Congress. While its expert, consensus committees are vital to its advisory role, HMD also convenes a series of forums, roundtables, and standing committees, as well as other activities, to facilitate discussion; discovery; and critical, cross-disciplinary thinking.

Forum on Drug Discovery, Development, and Translation: 2022 Annual Review Get This Book
×
 Forum on Drug Discovery, Development, and Translation: 2022 Annual Review
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Last year the Forum on Drug Discovery, Development, and Translation, helped to envision a transformed clinical trials enterprise for 2030–one that is more efficient, effective, and person-centered. In 2022, the Forum championed the inclusion of under-represented and underserved populations in clinical trials, drug research and development for adults across the older age span, and innovation in drug research and development for patients with chronic diseases. Learn more in this 2022 Annual Report.

READ FREE ONLINE

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  6. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  7. ×

    View our suggested citation for this chapter.

    « Back Next »
  8. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!